Literature DB >> 670422

Urinary free corticosteroid excretion and renal function.

J Gilliland, P J Phillips.   

Abstract

Theoretically urinary free corticosteroid excretion should be affected by renal function and this would make it a less sensitive index of hypercortisolaemia. In 28 consecutive urine samples there was a clear relationship (r = 0.83; P less than 0.001) over a range of creatinine clearances 0.3-200 ml/min. Although an allowance could be made for renal function this would not necessarily improve the discrimination of normal from abnormal. Until data comparing corrected to uncorrected urinary free corticosteroid excretion become available, we recommend a short dexamethasone test as the initial investigation in patients with suspected hypercortisolaemia and abnormal plasma creatinine concentrations.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 670422      PMCID: PMC1145372          DOI: 10.1136/jcp.31.7.671

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  3 in total

1.  Urinary excretion of free cortisol in impaired renal function.

Authors:  P Sederberg-Olsen; C Binder; H Kehlet
Journal:  Acta Endocrinol (Copenh)       Date:  1975-01

2.  Measurement of urinary free corticoids by competitive protein-binding radioassay in hypoadrenal states.

Authors:  T H Hsu; T Bledsoe
Journal:  J Clin Endocrinol Metab       Date:  1970-04       Impact factor: 5.958

3.  Cushing's syndrome. An evaluation of the clinical usefulness of urinary free cortisol and other urinary steroid measurements in diagnosis.

Authors:  C W Burke; C G Beardwell
Journal:  Q J Med       Date:  1973-01
  3 in total
  2 in total

1.  Applications of a modified Cortipac procedure for the estimation of urinary free cortisol in various clinical situations.

Authors:  P West
Journal:  J Clin Pathol       Date:  1980-01       Impact factor: 3.411

2.  The midnight-to-morning urinary cortisol increment method is not reliable for the assessment of hypothalamic-pituitary-adrenal insufficiency in patients with end-stage kidney disease.

Authors:  Y Oguz; C Oktenli; M Ozata; T Ozgurtas; Y Sanisoglu; M Yenicesu; A Vural; F Bulucu; I H Kocar
Journal:  J Endocrinol Invest       Date:  2003-07       Impact factor: 4.256

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.